Anuh Pharma, a company in the Pharmaceuticals industry, reported revenue of ₹185 crore and net profit of ₹11 crore for the September 2026 quarter.
Anuh Pharma (NSE: ANUHPHR) closed at ₹79.28 on 20 Nov 2026, down 1.2% over the past year. Its market capitalisation is ₹795 crore and it trades at 16.6 times earnings.
Incorporated in 1960, Anuh Pharma Ltd is in the business of manufacturing and selling of Bulk drugs and chemicals
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.